CYP2C19 and ischemic stroke: In the present study, we aimed to investigate whether mediators, SNPs, and promoter methylation of the genes participating in COX and ALOX metabolism and cytochrome P450 2C19 (CYP2C19) activation could be factors to predict the aspirin and clopidogrel resistance together with the cardiovascular risk factors in patients with ischemic stroke.